MAPK14 and nonpapillary renal cell carcinoma: In contrast, NPRC consistently acts as a tumor suppressor across multiple cancers (e.g., ccRCC, OS, HCC, CRC), inhibiting proliferation, promoting apoptosis, and suppressing metastasis, often via pathways like PI3K/AKT or p38-MAPK.